Skip to main content
. 2006 Jul;90(7):839–843. doi: 10.1136/bjo.2005.086322

graphic file with name bj86322.f2.jpg

Figure 2 LogMAR visual acuity measured on Snellen charts and the peak to peak amplitude of nystagmus measured in the worse eye (eye with the maximum amplitude of nystagmus) before and after treatment with gabapentin, in patients with multiple sclerosis (A and B); idiopathic infantile nystagmus and nystagmus associated with ocular pathology (C and D); and patients with MS treated with memantine (E and F).